ncRNA name
hsa-miR-203
Specific or universal ncRNAs
Specific ncRNAs
Class
MicroRNA
Biomarker
No
Biomarker application
Upstream regulatory factors
Not available
Downstream target
SIK2
Cancer name
Colorectal Cancer
Cancer site
Colon, Rectum, and Anus
Treatment type
Chemotherapy
Drug
Paclitaxel
Impact of wild-type ncRNA on chemotherapy resistance
Impact of knockdown of ncRNA on chemotherapy resistance
Impact of overexpression of ncRNA on chemotherapy resistance
Down
ncRNA differential expression in
cancer
patients vs. healthy people
Not available
Number of patients
Not available
Male patients
Not available
Female patients
Not available
Age range and number
Not available
PMID
Description
Overexpression of miR-203 sensitizes paclitaxel-resistant colorectal cancer cells through targeting the salt-inducible kinase 2.
Tissue resource
colon tumor tissues and the corresponding adjacent noncancerous tissues
human normal colon cell lines CCD-18Co
human normal colon cell lines CCD-33Co
Experiment
qRT-PCR,Western blot,Luciferase reporter assay
Institute
China-Japan Union Hospital of Jilin University
American Type Culture Collection
Country
China
USA
Continent
Asia
Amercia